OpGen
In Brief This Week: T2 Biosystems, Novacyt, OpGen, Dante Genomics, Nautilus Biotechnology, More
News items for the week of Jan. 23, 2023.
In Brief This Week: Burning Rock Biotech, Biocartis, NYGC, Eagle Genomics, Theradiag, OpGen, More
News items for the week of Jan. 16, 2023.
MDx Firm OpGen Prices $7.5M Public Offering
The Maryland-based firm announced the public offering of common stock and warrants one day after announcing a 1-for-20 reverse stock split to help regain Nasdaq compliance.
OpGen Announces 1-for-20 Reverse Stock Split
The molecular diagnostics firm recently reported a sharp decline in third quarter revenues amid an increased net loss.
People in the News at Biological Dynamics, Bionano Genomics, DNA Script, Pleno, NeoGenomics, More
Executive appointments, promotions, and departures in omics and molecular diagnostics for the week of Nov. 7, 2022.
Sep 30, 2022
OpGen to Raise $3.4M in Direct Stock Offering
Sep 20, 2022
FIND, Curetis Ink R&D Collaboration Agreement
Mar 30, 2022